International journal of surgery (London, England)
Construction and validation of a disulfidptosis-related risk assessment model for prediction of prognosis, immune microenvironment, drug therapy and microbiota in patients with low grade glioma.
Jiayang Han, Binbin Zhao, Man Yue, Mengwen Hou, Xu Han, Tiantian Sun, Ruohan Yun, Yuanyuan Dai, Junru Jia, Haiqiang Wang, Pengkun Li, Guosen Zhang, Yang An, Dayong Wang
Published: 202510.1097/JS9.0000000000003921
Abstract
BACKGROUND: Disulfidptosis has been recently identified as a mode of programmed cell death, which is becoming a promising target for tumor treatment. However, its biological mechanism in low-grade glioma (LGG) has not yet been thoroughly investigated…
Preview only. Read the full abstract at the source